SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Laube Lynne Marie

(Last) (First) (Middle)
C/O CARDLYTICS, INC.
675 PONCE DE LEON AVENUE NE, SUITE 6000

(Street)
ATLANTA GA 30308

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Cardlytics, Inc. [ CDLX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/21/2019
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/21/2019 S(1) 5,740 D $37.99(2) 282,257 D
Common Stock 10/22/2019 S(3) 639 D $37.3(4) 20,116 I See Footnote(5)
Common Stock 10/22/2019 S(3) 91 D $37.93(6) 20,025 I See Footnote(5)
Common Stock 10/22/2019 S(7) 640 D $37.3(4) 20,115 I See Footnote(8)
Common Stock 10/22/2019 S(7) 90 D $37.93(9) 20,025 I See Footnote(8)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 5, 2018, as amended May 14, 2019.
2. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $37.40 to $38.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (6) and (9) to this Form 4.
3. These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustees of the 2013 Lynne Marie Laube GRAT fbo Keegan George Allbright (the "KGA GRAT") on May 14, 2019.
4. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $36.76 to $37.75, inclusive.
5. The reportable securities are held by the KGA GRAT. The Reporting Person is the trustee of the KGA GRAT.
6. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $37.85 to $38.15, inclusive.
7. These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustees of the 2013 Lynne Marie Laube GRAT fbo Hayley Marie Allbright (the "HMA GRAT") on May 14, 2019.
8. The reportable securities are held by the HMA GRAT. The Reporting Person is the trustee of the HMA GRAT.
9. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $37.85 to $38.00, inclusive.
Remarks:
/s/ Kirk Somers, Attorney-in-Fact 10/23/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.